
|Articles|August 1, 2002
Derm drugs pose serious fetal risks
New York - A number of drugs used commonly in dermatology have teratogenic potential, making careful screening and comprehensive and ongoing pregnancy prevention counseling a must when prescribing medications for female patients, Robyn Gmyrek, M.D., said.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
Top 5 Articles of the Week: December 7-12
4
Transformative Advances This Year and Beyond
5


















